Ongoing, recruitingHuman Pharmacology (Phase I)- OtherInterventional

A study to test how well different doses of BI 1584862 are tolerated by healthy men

At a glance

Status

Ongoing, recruiting

Phase

Human Pharmacology (Phase I)- Other

Sponsor

Boehringer Ingelheim International GmbH

Enrolment target

50

Start

25 Jul 2023

Healthy volunteer trial

Who may be eligible?

Age 18 Years to any · Sex: Male

Locations (1)

—
Germany

How to find out more

Official trial record

Always speak to your GP or specialist before deciding to take part in a study.

Discussion

Community discussion

Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.